SUCCESSFUL PALLIATIVE PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR IMPENDING COMPRESSION OF VENA CAVA DUE TO UNRESECTABLE LIVER METASTASIS OF NEUROENDOCRINE TUMOR

Bahar Ataeinia, Christina Loberg, Hanna Kravets, Mohsen Beheshti, Dirk von Mallek, Felix M. Mottaghy, Alexander Heinzel*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We present the case of a 77 year old male patient with metastatic pancreatic neuroendocrine tumor (NET). The patient was initially treated by extensive surgical resection that however, led to severe complications with delayed recovery. During follow-up, a number of new liver metastases were detected, one of which was in segment I with impending compression of the inferior vena cava. Due to age and general condition of the patient, instead of further surgical treatment, the patient received four cycles of Lu-177-DOTATOC resulting in an overall partial response with successful tumor reduction in liver segment I, resolving an impending compression of vena cava.

Original languageEnglish
Pages (from-to)273-276
Number of pages4
JournalExcli Journal
Volume18
DOIs
Publication statusPublished - 2019

Keywords

  • neuroendocrine tumors
  • metastasis
  • PRRT
  • Lu-177-DOTATOC
  • OBSTRUCTION

Fingerprint

Dive into the research topics of 'SUCCESSFUL PALLIATIVE PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR IMPENDING COMPRESSION OF VENA CAVA DUE TO UNRESECTABLE LIVER METASTASIS OF NEUROENDOCRINE TUMOR'. Together they form a unique fingerprint.

Cite this